pyrroles has been researched along with warfarin in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 38 (48.10) | 18.7374 |
1990's | 4 (5.06) | 18.2507 |
2000's | 10 (12.66) | 29.6817 |
2010's | 26 (32.91) | 24.3611 |
2020's | 1 (1.27) | 2.80 |
Authors | Studies |
---|---|
Raina, JL; Ravin, AW | 1 |
Boehmer, S; Hays, JB | 1 |
Kikuchi, Y; Nash, H | 1 |
Gellert, M; Heller, K; Yang, HL; Zubay, G | 1 |
Castora, FJ; Simpson, MV | 1 |
Abremski, K; Gottesman, S | 1 |
Bogdanova, ES; Gorlenko, ZM; Gragerov, AI; Larionov, OA; Mirkin, SM | 1 |
Drlica, K; Snyder, M | 1 |
Brown, PO; Cozzarelli, NR; Higgins, NP; Peebles, CL; Sugino, A | 1 |
McCarthy, D | 1 |
De Wyngaert, M; Hinkle, DC | 1 |
Johnson, J; Mahler, HR | 1 |
Ryan, MJ; Wells, RD | 1 |
Gellert, M; Itoh, T; O'Dea, MH; Tomizawa, J | 1 |
Matsuyama, K; Perrin, JH; Sen, AC | 1 |
Baydoun, S; de Schryver, F; Gibbs, NK; Knox, CN; Quanten, E; Roelandts, R; Truscott, TG; Young, AR | 1 |
Chilin, A; Gia, O; Mobilio, S; Palumbo, M; Rodighiero, P | 1 |
Cochran, DL; Janes, RL; Koren, JF | 1 |
Adriaens, P; De Schryver, FC; Degreef, H; Quanten, E; Roelandts, R | 1 |
DeBernardis, JF; Siuda, JF | 1 |
Kong, YL; Scannell, J | 1 |
Godfrey, JC; Hooper, IR; Keil, JG; Schreiber, RH; Swanson, CL | 1 |
Chisholm, DR; Leitner, F; Misiek, M; Price, KE | 1 |
Hanoch, A; Michaeli, D; Mirelman, D; Molavi, A; Weinstein, L | 1 |
Filutowicz, M | 1 |
Pettijohn, DE; Pfenninger, O | 1 |
Baldi, MI; Benedetti, P; Mattoccia, E; Tocchini-Valentini, GP | 1 |
Edenberg, HJ | 1 |
Imamoto, F; Kano, Y; Kuroki, K; Miyashita, T; Nagata, A; Nakamura, H | 1 |
Godfrey, JC | 1 |
Francke, B; Margolin, J | 1 |
Ikeda, H; Matsumoto, T; Moriya, K | 1 |
Kholodií, GIa; Mindlin, SZ | 1 |
Danilevskaya, ON; Gragerov, AI | 1 |
Bremer, H; Choung, KK; Estiva, E | 1 |
O'Neill, PJ | 1 |
Ulitzur, S; Weiser, I; Yannai, S | 1 |
Chao, D; Luders, RC | 1 |
Hartley, JA; Haskell, MK; Lee, M; McAdam, SR; Roldan, MC | 1 |
Abel, R; Besserer, J; Gibson, GL; Stern, R | 1 |
Barnes, C; Bowers, B; Burnham, BS; Gupton, JT; Hall, IH; Krumpe, K; Shuford, J; Warren, AE; Webb, T | 1 |
Bushman, FD; Faulkner, DJ; Hansen, MS; Rao, MR; Reddy, MV; Rhodes, D; Rubins, K; Venkateswarlu, Y | 1 |
Bonnefoy, A; Dupuis-Hamelin, C; Ferroud, D; Haesslein, JL; Klich, M; Lassaigne, P; Laurin, P; Mauvais, P; Musicki, B; Periers, AM | 1 |
Peschko, C; Steglich, W; Winklhofer, C | 1 |
Ishibashi, F; Iwao, M; Oda, T; Tanabe, S | 1 |
Andrus, MR | 1 |
Dejaegere, AP; Schechner, M; Sirockin, F; Stote, RH | 1 |
Dorrestein, PC; Garneau, S; Kelleher, NL; Walsh, CT | 1 |
Molden, E; Westergren, T | 1 |
Hadjipavlou-Litina, DJ; Kontogiorgis, C; Litinas, KE; Makri, A; Nicolaides, DN; Pontiki, E; Siohou, A; Vronteli, A | 1 |
Chen, X; Liu, C; Peng, W; Qi, B; Wan, J; Yang, Q | 1 |
Baumert, C; Hilgeroth, A | 1 |
Fan, YH; Hu, T; Jia, G; Li, H; Tao, HR; Wang, HC; Zhang, RQ | 1 |
Cui, Y; Fan, A; Jia, Y; Jiang, J; Li, Q | 1 |
Charles, J; Miller, G; Pan, Y | 1 |
Sillence, D; Tchan, M | 1 |
Chedgy, F; Howlett, DC; Inglis, C | 1 |
Hwang, TL; Kuo, PC; Kuo, YC; Leu, YL; Lin, YT | 1 |
Akilli, H; Alihanoglu, Y; Altunkeser, BB; Aribas, A; Ayhan, S; Can, I; Demir, K; Koc, F; Vatankulu, MA | 1 |
Fenech, ME; Mackay, JW; Myint, KS | 1 |
Capon, RJ; Conte, M; Huang, XC; Khalil, Z; Piggott, AM; Plisson, F | 1 |
Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A | 1 |
Lin, CH; Yang, DY | 1 |
Brodsky, SV; Hebert, LA; Ivanov, I; Muni, N; Nadasdy, G; Nadasdy, T; Rovin, BH; Satoskar, AA; Vance, JC; Ware, KM | 1 |
Imbri, D; Opatz, T; Tauber, J | 1 |
Bharate, JB; Bharate, SB; Joshi, P; Khan, IA; Kumar, A; Sharma, S; Singh, S; Vishwakarma, RA; Wani, A | 1 |
Hadjmohammadi, M; Peyrovi, M | 1 |
He, L; Lin, W; Liu, Y; Wei, H; Xie, Y; Xu, Q; Zhu, S | 1 |
Dialer, C; Hansen, SP; Imbri, D; Opatz, T | 1 |
Manjappa, KB; Syu, JR; Yang, DY | 1 |
Aebischer, B; Akboga, MK; Akdamar, G; Alcalay, RN; Álvarez-Pérez, S; Aydogdu, S; Balci, KG; Barcaro, G; Bišová, K; Blanco, JL; Brewer, SH; Caruthers, SD; Ceylan, O; Chadwick, JA; Chang, DD; Che, JM; Chen, QQ; Chen, W; Chen, Z; Chung, M; Chung, W; Colecraft, HM; Coteli, E; Dogan, H; Dong, S; Elsig, S; Fahn, S; Fang, XJ; Feng, MG; Fenlon, EE; Floyd, KT; Fokdal, L; Ford, B; Fortunelli, A; Freudenberg, R; Gan-Or, Z; García, ME; Gillham, C; Giovannelli, D; Goertz, RS; Gulati, V; Haie-Meder, C; Hao, YY; Hatano, K; Hines, KJ; Hines, SM; Hirakawa, H; Hoskin, P; Hu, JH; Huang, P; Huang, Y; Hubicka, U; Inoue, Y; Ishii, N; Janssen, PM; Jin, Z; Johnson, A; Jürgenliemk-Schultz, I; Kaineder, K; Kamei, K; Kang, U; Karatas, F; Kash, TL; Katayama, Y; Keupp, J; Kirisits, C; Kisacik, H; Kodama, K; Kotzerke, J; Kryczyk, A; Kuhness, D; Kuo, S; Lanza, GM; Le Bris, N; Levin, DE; Levy, OA; Li, B; Li, H; Li, X; Liang, GD; Liang, Y; Liao, RQ; Lin, JT; Lindegaard, JC; Liong, C; Liu, B; Liu, C; Liu, GH; Liu, L; Liu, Q; Liu, X; Lowe, J; Lowery-Gionta, EG; Ma, YH; Maden, O; Mankad, V; Marder, KS; Marshall, SA; Martínez-Nevado, E; Maucksch, U; Mazeron, R; Mazzone, CM; Mazzoni, P; Mezricky, D; Mizokami, Y; Naumann, A; Navarro, M; Netzer, FP; Neurath, MF; Nie, Q; Oliva, P; Ozeke, O; Peláez, T; Pfeifer, L; Pleil, KE; Pomp, S; Pötter, R; Puckerin, AA; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Řezanka, M; Řezanka, T; Rinker, JA; Rouleau, GA; Runge, R; Sahin, MD; Sakai, A; Schmieder, AH; Schmitz, AJ; Schultz, EJ; Šegedin, B; Sementa, L; Shen, Y; Shiotsuki, I; Shirahama, M; Staley, J; Starovoytov, V; Sterrer, M; Strobel, D; Sturdza, A; Subramanyam, P; Surnev, S; Swager, SA; Taeymans, J; Tan, H; Tan, LT; Tanderup, K; Temizhan, A; Terao, T; Thiele, TE; Tran, T; Tucker, MJ; Vetriani, C; Vítová, M; Wang, JP; Wang, L; Wang, M; Wang, X; Waters, CH; Weng, SX; Wickline, SA; Wildner, D; Wodarcyk, AJ; Wolf, P; Wu, L; Wu, YL; Wunderlich, G; Xiong, L; Xu, P; Yang, GS; Yang, XN; Yang, Y; Yayla, C; Ying, SH; Zachleder, V; Zhang, XG; Zhang, XK; Zhang, Y; Zheng, JY; Zhong, WZ; Zhu, J; Zhu, YJ; Żmudzki, P | 1 |
Almodôvar, VAS; Cerqueira, AFR; Neves, MGPMS; Tomé, AC | 1 |
B Manjappa, K; Lin, JM; Yang, DY | 1 |
Liang, CG; Sun, YQ; Teng, P; Wang, JQ; Zhang, SG; Zhang, WH | 1 |
Bhardwaj, V; Bharti, R; Das, P; Kumari, S; Mazumder, AG; Purohit, R; Singh, D; Tanwar, G | 1 |
Weng, Z; Wu, CK; Yang, DY | 1 |
Awasthi, A; Khan, T; Kumar, V; Salam, A | 1 |
Huang, X; Li, Z; Liu, Y; Shi, S; Yang, C; Yang, T; Zhang, R; Zhang, Y; Zhou, J | 1 |
Ågren, H; Baryshnikov, GV; Deperasińska, I; Górski, K; Gryko, DT; Kamada, K; Ozaki, S | 1 |
8 review(s) available for pyrroles and warfarin
Article | Year |
---|---|
Naturally occurring halogenated organic compounds.
Topics: Alkaloids; Amino Acids; Animals; Anthraquinones; Bromine; Coumarins; Cyclopentanes; Esters; Fluorine; Griseofulvin; Halogens; Hydrocarbons, Halogenated; Indoles; Iodine; Ketones; Lipids; Phenols; Pyrroles; Quinones; Spiro Compounds; Terpenes; Tetracycline; Tyrosine; Xanthenes | 1973 |
The coumermycins: developments in the late 1970s.
Topics: Aminocoumarins; Animals; Chemical Phenomena; Chemistry; Coumarins; DNA Repair; DNA Replication; DNA Topoisomerases, Type II; Escherichia coli; Mitochondria, Liver; Models, Biological; Novobiocin; Pyrroles; Rats; Topoisomerase II Inhibitors; Transcription, Genetic | 1981 |
Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atorvastatin; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Indoles; International Normalized Ratio; Male; Patient Compliance; Pyrroles; Simvastatin; Venous Thrombosis; Warfarin | 2004 |
[Interaction risk with statin switch].
Topics: Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Atorvastatin; Diltiazem; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Hemorrhages; Muscular Diseases; Pyrroles; Risk Factors; Simvastatin; Warfarin | 2007 |
Recent advances in the development of P-gp inhibitors.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Coumarins; Drug Design; Drug Resistance, Neoplasm; Flavonoids; Humans; Peptides; Propafenone; Propanolamines; Pyrazoles; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolines; Structure-Activity Relationship; Tamoxifen; Terpenes; Verapamil | 2009 |
Synthetic approaches to the lamellarins--a comprehensive review.
Topics: Alkaloids; Coumarins; Heterocyclic Compounds, 4 or More Rings; Pyrroles | 2014 |
Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; Animals; Animals, Zoo; Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Antimanic Agents; Antioxidants; Aortic Valve; Area Under Curve; ATP Binding Cassette Transporter, Subfamily G, Member 2; Bacillus; Bacterial Toxins; Bacterial Typing Techniques; Base Composition; Beauveria; Binge Drinking; Biomarkers; Bipolar Disorder; Blood Coagulation; Blotting, Western; Brachytherapy; Calcium Channels, L-Type; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Wall; Cells, Cultured; Ceramics; Chi-Square Distribution; China; Chlorophyll; Chlorophyta; Chloroplasts; Cholesterol, HDL; Chromatography, High Pressure Liquid; Chromobacterium; Clostridium perfringens; Clozapine; Constriction, Pathologic; Coronary Artery Bypass; Corticotropin-Releasing Hormone; Cross-Sectional Studies; Cytochrome P-450 CYP2C9; Dental Porcelain; Dental Restoration Failure; Dental Stress Analysis; Designer Drugs; Diaminopimelic Acid; DNA Fingerprinting; DNA, Bacterial; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Dosage Calculations; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Elasticity Imaging Techniques; Epsilonproteobacteria; Equipment Design; Ericaceae; Excitatory Amino Acid Antagonists; False Negative Reactions; Fatty Acids; Female; Food Analysis; Fresh Water; Gene Expression Regulation, Neoplastic; Glutathione; Graft Occlusion, Vascular; Heart Valve Prosthesis Implantation; Heart Ventricles; HEK293 Cells; Hemolymph; Humans; Hyaluronan Receptors; Hydrogen Peroxide; Hydrothermal Vents; Indoles; Inflammation Mediators; Inhibitory Concentration 50; Insecta; International Normalized Ratio; Isotope Labeling; Itraconazole; Kidney; Kinetics; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lamotrigine; Lanthanoid Series Elements; Limit of Detection; Linear Models; Lipid Peroxidation; Liver; Liver Cirrhosis; Logistic Models; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Malondialdehyde; Mediastinum; Metronidazole; Mice; Mice, Nude; Mice, Transgenic; Microbial Sensitivity Tests; Microscopy, Fluorescence; Middle Aged; Monocytes; Monomeric GTP-Binding Proteins; Multivariate Analysis; Myocytes, Cardiac; Neoplasm Staging; Neoplastic Stem Cells; Neural Pathways; Nitrates; Nucleic Acid Hybridization; Octamer Transcription Factor-3; Odds Ratio; Oxidation-Reduction; Oxidative Stress; Peptidoglycan; Phantoms, Imaging; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Phospholipids; Photolysis; Photosynthesis; Phylogeny; Plant Extracts; Polychaeta; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyrimidines; Pyrroles; Quorum Sensing; Radiology, Interventional; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Reference Values; Regression Analysis; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhizosphere; Risk Factors; RNA, Ribosomal, 16S; ROC Curve; Rutin; Saphenous Vein; Seawater; Selenium; Semen Preservation; Sensitivity and Specificity; Septal Nuclei; Sequence Analysis, DNA; Serum Albumin; Serum Albumin, Human; Shear Strength; Sodium Pertechnetate Tc 99m; Sodium-Hydrogen Exchangers; Soil Microbiology; SOXB1 Transcription Factors; Spain; Species Specificity; Sperm Motility; Spermatozoa; Spheroids, Cellular; Spores, Fungal; Stroke; Superoxide Dismutase; Swine; Tandem Mass Spectrometry; Technetium Compounds; Technetium Tc 99m Exametazime; Technetium Tc 99m Sestamibi; Temperature; Thiosulfates; Thrombosis; Thyroid Neoplasms; Transducers; Transfection; Transplantation, Heterologous; Treatment Outcome; Triazines; Tumor Burden; Urocortins; Uterine Cervical Neoplasms; Vacuoles; Valproic Acid; Ventral Tegmental Area; Vitamin K 2; Vitamin K Epoxide Reductases; Warfarin; Water Microbiology; Young Adult | 2016 |
Coumarin-Tetrapyrrolic Macrocycle Conjugates: Synthesis and Applications.
Topics: Alkylation; Coumarins; Indoles; Isoindoles; Molecular Structure; Porphyrins; Pyrroles | 2017 |
2 trial(s) available for pyrroles and warfarin
Article | Year |
---|---|
Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
Topics: Analysis of Variance; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Chronic Disease; Electric Countershock; Female; Fibrinogen; Health Status Indicators; Heptanoic Acids; Humans; Leukocyte Count; Male; Middle Aged; Pyrroles; Secondary Prevention; Time Factors; Warfarin | 2011 |
Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers.
Topics: Adolescent; Adult; Cyclooxygenase 2 Inhibitors; Cytochrome P-450 CYP2C9; Genotype; Humans; Male; Pharmacogenomic Testing; Pyrroles; Sulfides; Vitamin K Epoxide Reductases; Warfarin | 2019 |
69 other study(ies) available for pyrroles and warfarin
Article | Year |
---|---|
Superhelical DNA in Streptococcus sanguis: role in recombination in vivo.
Topics: Aminocoumarins; Anti-Bacterial Agents; Biological Transport; Coumarins; DNA, Bacterial; DNA, Superhelical; Drug Resistance, Microbial; Pyrroles; Recombination, Genetic; Species Specificity; Streptococcus pneumoniae; Streptococcus sanguis; Transformation, Bacterial; Transformation, Genetic | 1979 |
Antagonists of DNA gyrase inhibit repair and recombination of UV-irradiated phage lambda.
Topics: Aminocoumarins; Anti-Bacterial Agents; Coliphages; Coumarins; DNA Repair; Oxolinic Acid; Pyrroles; Recombination, Genetic; Topoisomerase I Inhibitors; Ultraviolet Rays | 1978 |
Integrative recombination of bacteriophage lambda: requirement for supertwisted DNA in vivo and characterization of int.
Topics: Anti-Bacterial Agents; Bacteriophage lambda; Binding Sites; Coumarins; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; DNA, Viral; Genes, Regulator; Lysogeny; Pyrroles; Recombination, Genetic; Viral Proteins | 1979 |
Differential sensitivity of gene expression in vitro to inhibitors of DNA gyrase.
Topics: Anti-Bacterial Agents; Coumarins; DNA; DNA, Circular; DNA, Superhelical; Genes; Novobiocin; Oxolinic Acid; Plasmids; Protein Biosynthesis; Pyrroles; Topoisomerase II Inhibitors; Transcription, Genetic | 1979 |
Search for a DNA gyrase in mammalian mitochondria.
Topics: Animals; Anti-Bacterial Agents; Coumarins; DNA Topoisomerases, Type II; DNA, Mitochondrial; Kinetics; Mitochondria, Liver; Nalidixic Acid; Novobiocin; Oxolinic Acid; Pyrroles; Rats | 1979 |
The form of the DNA substrate required for excisive recombination of bacteriophage lambda.
Topics: Anti-Bacterial Agents; Bacteriophage lambda; Coumarins; DNA Topoisomerases, Type II; DNA, Superhelical; DNA, Viral; Hydrogen Bonding; Novobiocin; Pyrroles; Recombination, Genetic; Spermidine; Topoisomerase II Inhibitors | 1979 |
DNA supercoiling and transcription in Escherichia coli: influence of RNA polymerase mutations.
Topics: Aminocoumarins; Chromosomes, Bacterial; Coumarins; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Superhelical; Drug Resistance, Microbial; Escherichia coli; Mutation; Pyrroles; Topoisomerase II Inhibitors; Transcription, Genetic | 1979 |
Superhelical Escherichia coli DNA: relaxation by coumermycin.
Topics: Aminocoumarins; Anti-Bacterial Agents; Centrifugation; Chromosomes, Bacterial; Coumarins; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Mutation; Pyrroles | 1978 |
Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
Topics: Adenosine Triphosphate; Adenylyl Imidodiphosphate; Aminocoumarins; Anti-Bacterial Agents; Binding, Competitive; Coumarins; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Hydrolysis; Models, Chemical; Novobiocin; Nucleic Acid Conformation; Pyrroles | 1978 |
Gyrase-dependent initiation of bacteriophage T4 DNA replication: interactions of Escherichia coli gyrase with novobiocin, coumermycin and phage DNA-delay gene products.
Topics: Coliphages; Coumarins; DNA Replication; DNA, Bacterial; DNA, Superhelical; DNA, Viral; Drug Resistance, Microbial; Escherichia coli; Genes, Viral; Mutation; Nalidixic Acid; Novobiocin; Pyrroles; Virus Replication | 1979 |
Involvement of DNA gyrase in replication and transcription of bacteriophage T7 DNA.
Topics: Anti-Bacterial Agents; Coliphages; Coumarins; DNA Replication; DNA, Bacterial; DNA, Superhelical; DNA, Viral; Drug Resistance, Microbial; Escherichia coli; Mutation; Pyrroles; RNA, Viral; Transcription, Genetic; Viral Proteins | 1979 |
Specific effects of nalidixic acid on mitochondrial gene expression in Saccharomyces cerevisiae.
Topics: Anti-Bacterial Agents; Coumarins; DNA, Mitochondrial; Fungal Proteins; Genes; Mutation; Nalidixic Acid; Protein Biosynthesis; Pyrroles; Saccharomyces cerevisiae; Transcription, Genetic | 1979 |
Coumerimycin A1: A preferential inhibitor of replicative DNA synthesis in Escherichia coli. II. In vivo characterization.
Topics: Anti-Bacterial Agents; Coumarins; DNA Nucleotidyltransferases; DNA Replication; DNA-Directed RNA Polymerases; DNA, Bacterial; Escherichia coli; Mutation; Nucleic Acid Denaturation; Pyrroles; RNA, Bacterial; Temperature; Toluene | 1976 |
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Topics: Aminocoumarins; Anti-Bacterial Agents; Colicins; Coumarins; DNA Replication; DNA, Bacterial; DNA, Circular; DNA, Viral; Escherichia coli; Mutation; Novobiocin; Nucleic Acid Conformation; Plasmids; Pyrroles | 1976 |
The effects of pH, calcium and chloride ions on the binding of tolmetin to human serum albumin: circular dichroic, dialysis and fluorometric measurements.
Topics: Calcium; Chlorides; Circular Dichroism; Dialysis; Diazepam; Fluorometry; Humans; Hydrogen-Ion Concentration; Kinetics; Mathematics; Pyrroles; Serum Albumin; Tolmetin; Warfarin | 1987 |
Photophysical, photochemical and photobiological properties of pyrrolocoumarins; a new class of photoactive compounds.
Topics: Candida albicans; Coumarins; Drug Evaluation, Preclinical; Hemolysis; Humans; Molecular Structure; Photochemistry; Pyrroles; Radiation-Sensitizing Agents; Ultraviolet Rays | 1988 |
Pyrrolocoumarin derivatives: DNA-binding properties.
Topics: Coumarins; DNA; Molecular Structure; Nucleic Acid Denaturation; Pyrroles; Spectrometry, Fluorescence; Spectrophotometry; Structure-Activity Relationship; Ultraviolet Rays | 1988 |
Tolmetin-warfarin interaction.
Topics: Drug Interactions; Humans; Male; Middle Aged; Prothrombin Time; Pyrroles; Tolmetin; Warfarin | 1987 |
Photophysical behaviour of new pyrrolocoumarin derivatives.
Topics: Coumarins; Photochemistry; Pyrroles; Solvents; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 1986 |
Biosynthesis of coumermycin A1: incorporation of L-proline into the pyrrole groups.
Topics: Anti-Bacterial Agents; Coumarins; Proline; Pyrroles; Streptomyces | 1969 |
Preparation of semisynthetic coumermycin A1 derivatives. IV. Aliphatic acyl and related derivatives of 3-amino-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl) noviosyloxy] coumarin.
Topics: Anti-Bacterial Agents; Coumarins; Pyrroles | 1969 |
Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Coumarins; Infections; Mice; Microbial Sensitivity Tests; Pyrroles | 1969 |
Mode of action of coumermycin A: comparisons with novobiocin.
Topics: Anti-Bacterial Agents; Coumarins; DNA, Viral; Microbial Sensitivity Tests; Novobiocin; Pyrroles; RNA, Viral; Staphylococcus | 1970 |
Requirement of DNA gyrase for the initiation of chromosome replication in Escherichia coli K-12.
Topics: Aminocoumarins; Chromosome Mapping; Chromosomes, Bacterial; Coumarins; DNA Replication; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Escherichia coli; Genes; Mutation; Nalidixic Acid; Novobiocin; Pyrroles | 1980 |
Supercoils in prokaryotic DNA restrained in vivo.
Topics: Aminocoumarins; Coumarins; DNA Repair; DNA, Bacterial; DNA, Superhelical; Escherichia coli; F Factor; Gamma Rays; Nucleic Acid Conformation; Pyrroles; Topoisomerase II Inhibitors | 1980 |
In vitro catenation and decatenation of DNA and a novel eucaryotic ATP-dependent topoisomerase.
Topics: Adenosine Triphosphate; Aminocoumarins; Animals; Base Sequence; Coumarins; DNA Topoisomerases, Type I; DNA, Circular; DNA, Superhelical; Female; Magnesium; Oocytes; Osmolar Concentration; Ovum; Pyrroles; Spermidine; Xenopus | 1980 |
Novobiocin inhibition of simian virus 40 DNA replication.
Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; Depression, Chemical; DNA Replication; DNA, Superhelical; DNA, Viral; Novobiocin; Nucleic Acid Synthesis Inhibitors; Pyrroles; Simian virus 40; Topoisomerase II Inhibitors; Virus Replication | 1980 |
In vivo correlation between DNA supercoiling and transcription.
Topics: Aminocoumarins; Coliphages; Coumarins; DNA Topoisomerases, Type II; DNA, Superhelical; Escherichia coli; Nucleic Acid Conformation; Oxolinic Acid; Plasmids; Pyrroles; Templates, Genetic; Topoisomerase II Inhibitors; Transcription, Genetic | 1981 |
Effect of novobiocin and other DNA gyrase inhibitors on virus replication and DNA synthesis in herpes simplex virus type 1-infected BHK cells.
Topics: Aminocoumarins; Animals; Cell Division; Cell Line; Coumarins; Cricetinae; DNA; DNA, Viral; Nalidixic Acid; Novobiocin; Oxolinic Acid; Pyrroles; Simplexvirus; Topoisomerase II Inhibitors; Virus Replication | 1981 |
In vitro study of illegitimate recombination: involvement of DNA gyrase.
Topics: Aminocoumarins; Bacteriophage lambda; Base Sequence; Chromosome Deletion; Chromosome Mapping; Coumarins; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Viral; Escherichia coli; Oxolinic Acid; Plasmids; Pyrroles; Recombination, Genetic; Topoisomerase II Inhibitors | 1981 |
[Effect of coumermycin A1 and nalidixic acid on lambda phage integration and transducing lambdoid phages containing RNA-polymerase genes].
Topics: Aminocoumarins; Bacteriophage lambda; Coumarins; DNA-Directed RNA Polymerases; Escherichia coli; Lysogeny; Nalidixic Acid; Pyrroles; Transduction, Genetic | 1980 |
Curing of Escherichia coli K12 plasmids by coumermycin.
Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; DNA, Bacterial; Dose-Response Relationship, Drug; Escherichia coli; Plasmids; Pyrroles | 1980 |
Genetic and physiological characterization of a spontaneous mutant of Escherichia coli B/r with aberrant control of deoxyribonucleic acid replication.
Topics: Aminocoumarins; Anti-Bacterial Agents; Chromosome Mapping; Coumarins; DNA Replication; Escherichia coli; Genes; Mutation; Pyrroles; Temperature | 1981 |
Plasma protein binding of zomepirac sodium.
Topics: Animals; Blood Proteins; Humans; Macaca mulatta; Mice; Protein Binding; Pyrroles; Rats; Salicylates; Species Specificity; Tolmetin; Warfarin | 1981 |
DNA-damaging agents and DNA-synthesis inhibitors induce luminescence in dark variants of luminous bacteria.
Topics: Aminocoumarins; Coumarins; Enzyme Activation; Luciferases; Mitomycins; Mutation; Nalidixic Acid; Novobiocin; Photobacterium; Pyrroles; Ultraviolet Rays | 1981 |
Effect of pirprofen on protein binding of warfarin and tolbutamide in human plasma.
Topics: Anti-Inflammatory Agents; Humans; In Vitro Techniques; Phenylpropionates; Protein Binding; Pyrroles; Temperature; Tolbutamide; Warfarin | 1981 |
In vitro photoinduced cytotoxicity and DNA binding properties of psoralen and coumarin conjugates of netropsin analogues: DNA sequence-directed alkylation and cross-link formation.
Topics: Alkylation; Antineoplastic Agents; Base Composition; Coumarins; Cross-Linking Reagents; DNA; Ficusin; Furocoumarins; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Light; Molecular Structure; Netropsin; Photochemistry; Photochemotherapy; Pyrroles; Structure-Activity Relationship; Tumor Cells, Cultured | 1994 |
Atorvastatin does not alter the anticoagulant activity of warfarin.
Topics: Adult; Aged; Anticoagulants; Atorvastatin; Blood Coagulation; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prothrombin; Prothrombin Time; Pyrroles; Warfarin | 1997 |
Cytotoxicity of substituted alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 lymphoid leukemia cells.
Topics: Animals; Antineoplastic Agents; Coumarins; DNA; Enzyme Inhibitors; Enzymes; HeLa Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Isoquinolines; Leukemia L1210; Mice; Pyrazoles; Pyrroles; RNA; Structure-Activity Relationship | 1998 |
Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture.
Topics: Animals; Cell Line; Coumarins; Deoxyribonuclease HindIII; Enzyme Inhibitors; HeLa Cells; Heterocyclic Compounds, 4 or More Rings; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Inhibitory Concentration 50; Isoquinolines; Molluscum contagiosum virus; Pyrroles; Topoisomerase I Inhibitors; Urochordata; Virus Replication | 1999 |
Coumarin inhibitors of gyrase B with N-propargyloxy-carbamate as an effective pyrrole bioisostere.
Topics: Anti-Bacterial Agents; Carbamates; Coumarins; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Pyrroles; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2000 |
Alkaloids from marine organisms, Part 5. Biomimetic total synthesis of lamellarin L by coupling of two different arylpyruvic acid units.
Topics: Alkaloids; Animals; Antineoplastic Agents; Benzopyrans; Coumarins; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Mollusca; Pyrroles; Pyruvates | 2000 |
Synthesis and structure-activity relationship study of lamellarin derivatives.
Topics: Alkaloids; Animals; Chlorocebus aethiops; Coumarins; Dogs; Drug Screening Assays, Antitumor; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Isoquinolines; Kidney; Mitomycin; Molecular Structure; Mollusca; Pyrroles; Rats; Sarcoma; Structure-Activity Relationship; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |
Functionality maps of the ATP binding site of DNA gyrase B: generation of a consensus model of ligand binding.
Topics: Adenosine Triphosphate; Binding Sites; Computer Simulation; Coumarins; DNA Gyrase; Escherichia coli Proteins; Ligands; Models, Molecular; Pliability; Protein Binding; Pyrroles; Solvents; Structure-Activity Relationship | 2004 |
Characterization of the formation of the pyrrole moiety during clorobiocin and coumermycin A1 biosynthesis.
Topics: Amino Acid Sequence; Aminocoumarins; Chromatography, High Pressure Liquid; Coumarins; DNA Primers; Escherichia coli; Escherichia coli Proteins; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Novobiocin; Polymerase Chain Reaction; Pyrroles; Restriction Mapping; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2005 |
Synthesis and biological evaluation of novel angular fused Pyrrolocoumarins.
Topics: Anti-Inflammatory Agents; Antioxidants; Coumarins; Enzyme Inhibitors; Free Radical Scavengers; Glycine max; Humans; Lipoxygenase; Prothrombin Time; Pyrroles | 2008 |
Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats.
Topics: Animals; Aortic Diseases; Atorvastatin; Blood Pressure; Calcinosis; Heptanoic Acids; Hypertension; Male; Pyrroles; Random Allocation; Rats; Rats, Wistar; Warfarin | 2008 |
Atorvastatin reduces calcification in rat arteries and vascular smooth muscle cells.
Topics: Animals; Aorta, Abdominal; Atorvastatin; Calcinosis; Calcium; Cells, Cultured; Drug Combinations; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Injections, Subcutaneous; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pyrroles; Rats; Rats, Sprague-Dawley; Thoracic Arteries; Vitamin D; Warfarin | 2010 |
Total synthesis of lamellarins D, H, and R and ningalin B.
Topics: Aldehydes; Alkaloids; Amines; Catalysis; Coumarins; Cyclization; Heterocyclic Compounds, 3-Ring; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Marine Biology; Molecular Structure; Oxidation-Reduction; Pyrroles | 2011 |
TIAs - management in general practice.
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Dipyridamole; Dopamine Antagonists; General Practitioners; Heptanoic Acids; Humans; Hypolipidemic Agents; Ischemic Attack, Transient; Perindopril; Platelet Aggregation Inhibitors; Primary Health Care; Prochlorperazine; Pyrroles; Ticlopidine; Vasodilator Agents; Warfarin | 2010 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin | 2011 |
A case of recurrent ventricular tachycardia.
Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin | 2011 |
Chemical constituents from Lobelia chinensis and their anti-virus and anti-inflammatory bioactivities.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Butyrates; Cell Degranulation; Coumarins; Drugs, Chinese Herbal; HeLa Cells; Herpesvirus 1, Human; Humans; Isomerism; Leukocyte Elastase; Lobelia; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Neutrophils; Pyrroles; Superoxides; Viral Plaque Assay; Virus Replication; Young Adult | 2011 |
Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin.
Topics: Acute Disease; Aged; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Drug Interactions; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Pyrroles; Rhabdomyolysis; Warfarin | 2012 |
Kinase inhibitor scaffolds against neurodegenerative diseases from a Southern Australian ascidian, Didemnum sp.
Topics: Animals; Australia; Binding Sites; Carbazoles; Casein Kinase Idelta; Catechols; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Coumarins; Cyclin-Dependent Kinase 5; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Neurodegenerative Diseases; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrroles; Urochordata | 2012 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin | 2012 |
Synthesis of coumarin/pyrrole-fused heterocycles and their photochemical and redox-switching properties.
Topics: Coumarins; Heterocyclic Compounds; Hydrogenation; Oxidation-Reduction; Photochemical Processes; Pyrroles | 2013 |
Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?
Topics: Acetylcysteine; Animals; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzimidazoles; beta-Alanine; Blood Pressure; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radical Scavengers; Nephrectomy; Pyrroles; Quinazolines; Rats; Receptor, PAR-1; Renal Insufficiency, Chronic; Vitamin K; Warfarin | 2015 |
Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.
Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; Bacterial Proteins; Binding Sites; Biological Transport; Caco-2 Cells; Ciprofloxacin; Coumarins; Dogs; Ethidium; Humans; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Models, Molecular; Multidrug Resistance-Associated Proteins; Pyrroles; Rifampin; Staphylococcus aureus | 2015 |
Synthesis of molecularly imprinted polypyrrole as an adsorbent for solid-phase extraction of warfarin from human plasma and urine.
Topics: Adsorption; Anticoagulants; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Microscopy, Electron, Scanning; Molecular Imprinting; Polymers; Pyrroles; Solid Phase Extraction; Warfarin | 2015 |
Broadband Light-Harvesting Molecular Triads with High FRET Efficiency Based on the Coumarin-Rhodamine-BODIPY Platform.
Topics: Boron Compounds; Coumarins; Fluorescence Resonance Energy Transfer; Light; Photochemistry; Pyrroles; Rhodamines | 2015 |
Synthesis of Lamellarin D Trimethyl Ether and Lamellarin H via 6π-Electrocyclization.
Topics: Alkylation; Anions; Coumarins; Cyclization; Ethers; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Molecular Structure; Pyrroles; Stereoisomerism | 2015 |
Visible-Light-Promoted and Yb(OTf)3-Catalyzed Constructions of Coumarin-Pyrrole-(Iso)quinoline-Fused Pentacycles: Synthesis of Lamellarin Core, Lamellarin D Trimethyl Ether, and Lamellarin H.
Topics: Catalysis; Coumarins; Cyclization; Ethers; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Light; Mesylates; Molecular Structure; Nitro Compounds; Organometallic Compounds; Pyrroles | 2016 |
Construction of Pentacyclic Lamellarin Skeleton via Grob Reaction: Application to Total Synthesis of Lamellarins H and D.
Topics: Coumarins; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Molecular Structure; Pyrroles; Stereoisomerism | 2017 |
Design, synthesis and antifungal activities of novel pyrrole- and pyrazole-substituted coumarin derivatives.
Topics: Antifungal Agents; Coumarins; Drug Design; Fungi; Plants; Pyrazoles; Pyrroles; Structure-Activity Relationship | 2019 |
Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures.
Topics: Animals; Anticonvulsants; Class I Phosphatidylinositol 3-Kinases; Coumarins; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy; Gene Expression Profiling; Gene Expression Regulation; Humans; Molecular Docking Simulation; Pentylenetetrazole; Proto-Oncogene Proteins c-akt; Pyrroles; Signal Transduction; TOR Serine-Threonine Kinases; Zebrafish; Zebrafish Proteins | 2019 |
One-Pot Construction of 1-Phenylchromeno[3,4- b]pyrrol-4(3 H)-one: Application to Total Synthesis of Ningalin B and a Pyrrolocoumarin-Based Electrochromic Switch.
Topics: Chemistry Techniques, Synthetic; Coumarins; Electrochemistry; Heterocyclic Compounds, 3-Ring; Pyrroles | 2019 |
Scalable Total Syntheses of Some Natural and Unnatural Lamellarins: Application of a One-Pot Domino Process for Regioselective Access to the Central 1,2,4-Trisubstituted Pyrrole Core.
Topics: Alkaloids; Biological Products; Coumarins; Cycloaddition Reaction; Heterocyclic Compounds, 4 or More Rings; Isoquinolines; Molecular Structure; Pyrroles | 2019 |
Quadrupolar Dyes Based on Highly Polarized Coumarins.
Topics: Coumarins; Electrons; Fluorescence; Molecular Structure; Photons; Pyrroles | 2021 |